Parexel International Corp - Strategic SWOT Analysis Review

Parexel International Corp - Strategic SWOT Analysis Review
- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

ScopeBusiness description – A detailed description of the company’s operations and business divisions.Corporate strategy – GlobalData’s summarization of the company’s business strategy.SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.Company history – Progression of key events associated with the company.Major products and services – A list of major products, services and brands of the company.Key competitors – A list of key competitors to the company.Key employees – A list of the key executives of the company.Executive biographies – A brief summary of the executives’ employment history.Key operational heads – A list of personnel heading key departments/functions.Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.Highlights

Parexel International Corp (Parexel), a subsidiary of Pamplona Capital Management LLP is a biopharmaceutical outsourcing service company. It provides services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers an array of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development, and commercialization consulting among others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in the Americas, Asia Pacific and EMEA countries across the world. Parexel is headquartered in Durham, North Carolina, the US.

Parexel International Corp Key Recent Developments

Aug 15,2023: Parexel and Partex Announce Innovative Alliance Leveraging Artificial Intelligence and Big Data to Accelerate Drug Discovery and Development
Apr 19,2023: Parexel Appoints Scott Smith, M.D., Ph.D. as New Head of Hematology
Feb 28,2023: Parexel Introduces Expert Series – New Medicines, Novel Insights
Dec 15,2022: Parexel teams with MyEyeDr. to increase patient access and participation in ophthalmology clinical trials

Reasons to BuyGain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.Note:Some sections may be missing if data is unavailable for the company.